Cetirizine Tablet Recall: Rising Pharma Lot PY925014, PY925013
Announced 2026-07-29 · FDA
FDA is recalling Cetirizine Hydrochloride Tablets USP due to imprint with an incorrect ID. About 13,440 bottles distributed nationwide are affected. Lot numbers PY925014 and PY925013 expire 1/31/2028; manufactured by Unique Pharmaceuticals Labs and distributed by Rising Pharma Holdings.
| Brand | JB Chemicals and Pharmaceuticals Ltd |
|---|---|
| Product | Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50 |
| Reason | Tablet/Capsules Imprinted with Wrong ID |
| Severity | low |
| Units affected | 34020 |
| Distribution | U.S. Nationwide |
| Agency | FDA |
WHAT YOU SHOULD DO
- Check your bottle for Lot PY925014 or PY925013 and stop using it if found.
- Return or discard affected bottles according to the recall instructions from Rising Pharma Holdings.
- If you have taken the product, contact your healthcare provider for advice.
- For more information, monitor FDA recall notices or contact the distributor/manufacturer listed.
How to identify the recalled item
| Lot / date codes | Lot # PY925014, PY925013, Exp. 1/31/2028 |
|---|---|
| Lot / date codes | Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.